½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1429014

¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå Æò°¡ : Á¦Ç°º°, °¡µ¿¼ºº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2017-2031³â)

Fundus Camera Market Assessment, By Product, By Portability, By End-user, By Region, Opportunities and Forecast, 2017-2031F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Xcel - Markets and Data | ÆäÀÌÁö Á¤º¸: ¿µ¹® 229 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 4,869¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â 7¾ï 123¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, ¿¹Ãø±â°£ÀÎ 2024³âºÎÅÍ 2031³â±îÁö CAGR 5.74%ÀÇ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ½Ã·Â Àå¾Ö À¯º´·ü Áõ°¡, ³ë³â Àα¸ Áõ°¡, Á¶±â Áø´ÜÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, ÷´Ü ±â¼úÀ» ÀÌ¿ëÇÑ ¾ÈÀú Ä«¸Þ¶óÀÇ µµÀÔ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ¾ß±âµË´Ï´Ù. °Ô´Ù°¡ Çõ½ÅÀûÀΠ÷´Ü ¾ÈÀú Ä«¸Þ¶óÀÇ ¿¬±¸ °³¹ß¿¡ À־ÀÇ Á¤ºÎÀÇ Áö¿ø, ´ëó, Á¤Ã¥, ÇÁ·Î±×·¥, ¹Î°£ ±â¾÷¿¡ ÀÇÇÑ ÅõÀÚ Áõ°¡°¡ ¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÕ´Ï´Ù.

¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀåÀº Á¶±â ¹× Á¤È®ÇÑ Áø´ÜÀ» À§ÇÑ ¾ÈÀú Ä«¸Þ¶ó ¼ö¿ä¸¦ Áõ°¡½ÃÅ°´Â ½Ã·Â Àå¾ÖÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç×»ó °­·ÂÇÑ ¼ºÀåÀ» º¸ÀÌ°í ÀÖ½À´Ï´Ù. ³ë³â Àα¸ Áõ°¡´Â ½Ã·Â Àå¾ÖÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¼¼°èÀÇ °í·ÉÈ­¿¡ µû¶ó Ȳ¹Ý º¯¼ºÁõ, ³ì³»Àå, Áõ½Ä ´ç´¢º´ ¸Á¸·Áõ, ³ë¾È µîÀÇ ¾È°ú ÁúȯÀ» ¹ßº´Çϱ⠽¬¿öÁö°í ÀÖ½À´Ï´Ù. ¾ÈÀú Ä«¸Þ¶ó´Â ¾È±¸ÀÇ »ó¼¼ÇÑ Æò°¡, ¸Á¸·ÀÇ »ó¼¼ÇÑ Æò°¡, ¾È±¸¿Í °ü·ÃµÈ ¸ðµç À¯ÇüÀÇ Áúº´¿¡ ´ëÇÑ Æò°¡¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Áøº¸, Á¦Ç° Ãâ½Ã, °¡Ã³ºÐ ¼Òµæ Áõ°¡, Á¤ºÎ À̴ϼÅƼºê, ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ¾ÈÀú Ä«¸Þ¶ó¿¡ ´ëÇÑ ¾×¼¼½º Áõ°¡´Â ¼¼°è ¾ÈÀú Ä«¸Þ¶ó ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

½Ã·ÂÀå¾ÖÀÎ Áõ°¡

¼¼°èÀÇ ½Ã·Â Àå¾Ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á Á¦°ø¾÷üÀÇ ¾ÈÀú Ä«¸Þ¶ó¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ÀÖ½À´Ï´Ù. ³ëÀÎÀº ¹é³»Àå, ±Ù½Ã, ¿ø½Ã, ´ç´¢º´ ¸Á¸·Áõ, ³ì³»Àå, ³ëÈ­ Ȳ¹Ý º¯¼º, ³ë¾È°ú °°Àº ´«°ú °ü·ÃµÈ Áúº´À» ¹ßº´Çϱ⠽±½À´Ï´Ù. WHO¿¡ µû¸£¸é Àü ¼¼°èÀûÀ¸·Î 22¾ï ¸íÀÌ ±Ù½Ã ¶Ç´Â ¿ø½Ã Àå¾Ö¸¦ °®°í ÀÖÀ¸¸ç Á¶±â ¹ß°ß, Á¤È®ÇÑ Áø´Ü, Áúº´ °ü¸® µîÀÇ ¿¹¹æ Á¶Ä¡°¡ ÀûÀýÇÑ ½Ã±â¿¡ Á¦°øµÇ¸é ÀÌ·¯ÇÑ °æ¿ìÀÇ ¾à 50%¸¦ ¸·À» ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. ½Ã·Â Àå¾ÖÀÇ À¯º´·üÀº ÁßÀú¼Òµæ ±¹°¡¿¡¼­ °¡Àå ³ô½À´Ï´Ù. ½Ã·Â Àå¾ÖÀÇ Ä¡·á¿¡´Â Á¤È®ÇÑ Á¶±â Áø´ÜÀ» À§ÇÑ ¾ÈÀú Ä«¸Þ¶ó »ç¿ë°ú °°Àº ¾È°æ¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀ» ÅëÇÑ Á¶±â ¹ß°ß ¹× Á¶±â °³ÀÔÀÌ ÇʼöÀûÀÔ´Ï´Ù.

±â¼ú Áøº¸°¡ ½ÃÀå Çõ½Å ÃËÁø

½Ã·ÂÀå¾ÖÀÇ À¯º´·üÀÌ ³ô±â ¶§¹®¿¡ º¸´Ù »ó¼¼ÇÑ ºÐ¼®¿¡ ÀÌ¿ëÇÏ´Â ¾ÈÀú Ä«¸Þ¶ó µîÀÇ Á¶±â ¹ß°ß ÀåÄ¡ÀÇ ±â¼ú Çõ½ÅÀ» °¡¼ÓÈ­ÇÏ´Â °Í¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù. AI¸¦ ¾ÈÀú Ä«¸Þ¶ó¿¡ ÅëÇÕÇÏ¸é ¾Ë°í¸®ÁòÀÌ ¾ÈÀú »çÁø°ú OCT¸¦ µ¿½Ã¿¡ ºÐ¼®ÇÒ ¼ö ÀÖ¾î ½Å¼ÓÇÏ°í È¿À²ÀûÀÎ ¾È°ú °ËÁøÀÌ °¡´ÉÇÕ´Ï´Ù. ¼ÒºñÀÚÀÇ ´« °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä ¹× ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¦Á¶¾÷ü´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϱâ À§ÇØ ¿¬±¸ °³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇÏ°í ÀÖ½À´Ï´Ù. 2023³â 6¿ù AI ±â¹Ý ¾ÈÀú Ä«¸Þ¶ó ¹× AI ¿¹Ãø ¹ÙÀÌ¿À ¸¶Ä¿¸¦ Æ÷ÇÔÇÑ AI ±â¹Ý µðÁöÅÐ °Ç°­ Á¦Ç° Á¦Á¶ÀÇ ¼¼°èÀû ¸®´õÀÎ EyenukÀº ÃÖ±Ù TopconÀÇ NW400 ¸Á¸· Ä«¸Þ¶ó¿Í AI¸¦ ÅëÇÕÇϱâ À§ÇÑ ¹Ì±¹ FDA Çã°¡¸¦ ¹ÞÀ¸¸é ÀÚµ¿È­ ¹× ´ç´¢º´ ȯÀÚ¸¦ À§ÇÑ ³ôÀº Á¤È®µµ·Î ´ç´¢º´ ¸Á¸·ÁõÀ» °¨ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

Á¤ºÎÀÇ À̴ϼÅƼºê

¾È°ú Ŭ¸®´Ð°ú °°Àº ¾È°ú ÀÇ·á ½Ã¼³Àº ¼¼°èÀÇ ¾È°ú ÀÇ·á¿¡¼­ ÇʼöÀûÀÎ Á¸ÀçÀÔ´Ï´Ù. ¾ÈÁúȯ ºÎ´ã Áõ°¡ ¹× ÷´Ü Áø´Ü ÀåºñÀÇ Çʿ伺À» ÀνÄÇÏ°í ¸¹Àº Á¤ºÎ°¡ ¾È°ú Áø´Ü ÀåºñÀÇ Ã¤¿ëÀ» Áö¿øÇÏ´Â ÀÇ·á Á¤Ã¥°ú ³ë·ÂÀ» ¼ö¸³ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áø´Ü Àåºñ °³¹ß¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø, ¿¬±¸ º¸Á¶±Ý, º¸Á¶±Ý µîÀÇ ÇÁ·Î±×·¥Àº ÀÇ·á ½Ã¼³°ú °³¾÷ Àǻ簡 ÀÌ·¯ÇÑ Àåºñ¸¦ Áø·á¿¡ µµÀÔÇϵµ·Ï ±ÇÀåÇÕ´Ï´Ù.

¿¹¸¦ µé¾î 2023³â 5¿ù, National Health Service(NHS)´Â ¾ÈÀú Ä«¸Þ¶ó¿Í °°Àº ÃֽŠµðÁöÅÐ Áø´Ü ÀåºñÀÇ µµ¿òÀ¸·Î À×±Û·£µå ȯÀÚÀÇ ¾È°ú ÀÇ·á ¼­ºñ½º ´ë±â ½Ã°£À» ´ÜÃàÇÏ°í °³¼±µÈ È¿À²ÀûÀÎ ¾È°ú ÀÇ·á Áø´Ü ¹× Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â »õ·Î¿î ÀÓ»ó ÁöħÀÇ ÀÌÇàÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ°ÍÀº ȯÀÚÀÇ ¾È°ú Ä¡·áÀÇ ¼Óµµ ¹× ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. °á°úÀûÀ¸·Î ÀÌ·¯ÇÑ Á¤ºÎÀÇ À̴ϼÅƼºê´Â ¼¼°è ¾ÈÀú Ä«¸Þ¶ó ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ½ÃÀå ¿ªÇÐ, ÁÖ¿ä ±â¾÷ »óȲ ¹× Àü¸Á µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÇÁ·ÎÁ§Æ®ÀÇ ¹üÀ§ ¹× Á¤ÀÇ

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå Àü¸Á(2017-2031³â)

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • ±Ý¾×
    • ¼ö·®
  • Á¦Ç°º°
    • »êµ¿ ¾ÈÀú Ä«¸Þ¶ó
    • ¹«»êµ¿ ´« ¹Ù´Ú Ä«¸Þ¶ó
    • ÇÏÀ̺긮µå ¾ÈÀú Ä«¸Þ¶ó
    • ±âŸ
  • °¡µ¿¼ºº°
    • ÈÞ´ëÇü
    • Å×ÀÌºí °ÅÄ¡Çü
  • ÃÖÁ¾ »ç¿ëÀÚº°
    • º´¿ø ¹× Ŭ¸®´Ð
    • ¾È°ú Ŭ¸®´Ð
    • ±âŸ
  • Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ³²¹Ì
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå Á¡À¯À² : ±â¾÷º°(2023³â)

Á¦5Àå ¼¼°èÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå Àü¸Á : Áö¿ªº°(2017-2031³â)

  • ºÏ¹Ì
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • Á¦Ç°º°
    • °¡µ¿¼ºº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½ºÆäÀÎ
    • ÅÍÅ°
    • Æú¶õµå
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • È£ÁÖ
    • º£Æ®³²
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ³²¾ÆÇÁ¸®Ä«

Á¦6Àå ½ÃÀå ¸ÅÇÎ(2023³â)

  • Á¦Ç°º°
  • °¡µ¿¼ºº°
  • ÃÖÁ¾ »ç¿ëÀÚº°
  • Áö¿ªº°

Á¦7Àå °Å½ÃÀû ȯ°æ ¹× »ê¾÷ ±¸Á¶

  • ¼ö±Þ ºÐ¼®
  • ¼öÃâÀÔ ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTEL ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ(°úÁ¦ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ)

Á¦9Àå ±ÔÁ¦ Ʋ ¹× Çõ½Å

  • ÀÓ»ó ½ÃÇè
  • ƯÇã »óȲ
  • ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ
  • Çõ½Å ¹× ½Å±â¼ú

Á¦10Àå ÁÖ¿ä ±â¾÷ Á¤¼¼

  • ¸¶ÄÏ ¸®´õ »óÀ§ 5°³»çÀÇ °æÀï ¸ÅÆ®¸¯½º
  • ¸¶ÄÏ ¸®´õ »óÀ§ 5°³»ç ½ÃÀå ¼öÀÍ ºÐ¼®(2023³â)
  • ÇÕº´, Àμö ¹× ÇÕÀÛ»ç¾÷(ÇØ´çÇÏ´Â °æ¿ì)
  • SWOT ºÐ¼®(½ÃÀå Âü°¡ ±â¾÷ 5»ç)
  • ƯÇ㠺м®(ÇØ´çÇÏ´Â °æ¿ì)

Á¦11Àå °¡°Ý ºÐ¼®

Á¦12Àå »ç·Ê ¿¬±¸

Á¦13Àå ÁÖ¿ä ±â¾÷ÀÇ Àü¸Á

  • Topcon Corporation
  • Kowa Company, Ltd.
  • Canon Inc.
  • Forus Health Pvt Ltd
  • Nidek Co., Ltd.
  • Remidio Innovative Solutions Pvt. Ltd.
  • Epipole Ltd
  • Coburn Technologies, Inc.
  • Carl Zeiss AG
  • Tamron Co., Ltd.
  • Revenio Group Corporation
  • Optomed Plc.
  • Eyenuk Inc.

Á¦14Àå Àü·«Àû ±ÇÀå»çÇ×

Á¦15Àå ȸ»ç¼Ò°³ ¹× ¸éÃ¥»çÇ×

AJY 24.03.04

Global fundus camera market is projected to witness a CAGR of 5.74% during the forecast period 2024-2031, growing from USD 448.69 million in 2023 to USD 701.23 million in 2031. Growth in the global fundus camera market is driven by various factors, such as the growing prevalence of vision impairments, an increase in the elderly population, growing awareness about the importance of early diagnosis, and the introduction of technologically advanced fundus cameras. Moreover, government support, initiatives, policies, and programs in research and development for innovative and advanced fundus cameras and increasing investments by private companies will further promote growth in the global fundus camera market.

The global fundus camera market is consistently undergoing robust growth due to the increasing prevalence of vision impairment, which is increasing the demand for fundus cameras for early and accurate diagnosis. The growing geriatric population is the major cause of vision impairment. As global population grows older, they are prone to develop ophthalmic diseases such as macular degeneration, glaucoma, proliferative diabetic retinopathy, and presbyopia. Fundus camera has the potential to provide in-depth evaluation of the eye, detailed assessment of retina, and evaluation of any kind of diseases associated with the eye. Technological advancements, product launches, increased disposable incomes, government initiatives, and increasing access to fundus cameras in low and middle-income countries are some of the factors driving the global fundus camera market growth.

Increasing Number of Patients with Vision Impairments

There has been a surge in demand for fundus cameras by healthcare providers due to the rising number of vision impairments worldwide. Geriatric people are prone to develop eye related issues such as cataract, myopia, hyperopia, diabetic retinopathy, glaucoma, age related macular degeneration, and presbyopia. According to WHO, 2.2 billion people have a near or distance vision impairment globally and it is also stated that, out of these, around 50% of these cases could be prevented if access to preventive measures, such as early detection, accurate diagnosis, and diseases management, would be provided at the right time. The prevalence of vision impairment is most common in low- and middle-income countries. Early detection and early intervention by improved access to eyewear, such as using fundus cameras for accurate and early diagnosis for timely management, are crucial in treating vision impairments.

Technological Advancements are Driving Innovation in the Market

With the high prevalence of vision impairment cases, there is a high demand for expediting innovation in early detection devices, such as fundus cameras, for better in-depth analysis. Integrating AI with fundus camera enables the algorithm to analyze fundus photography and OCT simultaneously, thus offering fast and efficient eye screening. As consumers become more aware and conscious of their eye health, manufacturers continuously invest in research and development to meet this growing demand for innovative solutions. In June 2023, Eyenuk, a global leader in manufacturing AI based digital health products, such as AI-based fundus cameras and AI predictive biomarkers, recently received U.S. FDA clearance to integrate AI with Topcon NW400 retinal camera, which will help in detecting diabetic retinopathy with automation and high precision for diabetic patients.

Government Initiatives

Eye care facilities, such as eye ophthalmic clinics, are essential part of ophthalmology worldwide. Recognizing the growing burden of eye diseases and the need for advanced diagnostic devices, many governments have formulated healthcare policies and initiatives to support the adoption of ophthalmic diagnostic devices. Programs for funding, grants for research, and subsidies for the development of these diagnostic devices have encouraged medical facilities and practitioners to incorporate these devices into their practices.

For instance, in May 2023, National Health Service (NHS) England announced implementation of a new clinical guidance, which could reduce waiting times for eye care services for patients in England as well as provide improved efficient eye care diagnosis and treatment with the help of latest digital diagnostic appliances such as fundus cameras. This, in turn, will improve the speed and quality of eye care treatment for patients. As a result, such initiatives by the government help enhance growth in the global fundus camera market.

Growth in Non-Mydriatic Fundus Cameras

Among the product segment, non-mydriatic fundus camera is expected to grow with a faster rate. Technological advancements in this segment have led to the emergence of advanced products, such as AI-based fundus cameras, that enhance its photography capability. Non-mydriatic cameras have the potential to provide early detection and monitoring of several serious eye health conditions without pupil dilation and pain. Due to this, there has been a tremendous demand among patients and healthcare providers, further driving this segment's growth. Many key market players understand the growing demand of this segment and are launching non-mydriatic fundus cameras.

In October 2023, Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care industry, announced launch of NW500 to the European market. The NW500 is a robotic colour fundus camera that provides enhanced image quality in ambient light. It has a touch-screen capability that enables users to capture images rapidly with just one touch. It is fully automated, easy to use, and enhances the overall efficiency of the fundus photography workflow, which is gaining popularity among healthcare providers.

North America Holds the Largest Share in Fundus Camera Market

North America accounts for the highest share in the global fundus camera market. The United States offers a strong infrastructure and advanced healthcare facilities, making it a hub for cutting-edge medical technology, including sophisticated fundus cameras. People are becoming more conscious about the advantages of early detection and screening in the fight against eye diseases. In addition to these variables, the number of people with diabetes in North America is rising. Diabetes has a significant impact on the eyes, which increases the incidence of eye conditions like diabetic retinopathy. Moreover, the presence of key market players like Coburn Technologies, Inc and Eyenuk Inc. plays a pivotal role in promoting growth in the fundus camera market in the region. One million Americans suffer from blindness, and six million Americans have vision impairment. People under 40 years account for more than 1.6 million blind or visually impaired population. More than 350,000 blind or visually impaired people reside in nursing homes or prisons in the United States.

Future Outlook

The global fundus camera market is expected to grow in the coming years due to the increasing geriatric population, which is more prone to developing eye-related diseases. Fundus cameras are cost-effective and plays a crucial role in providing early intervention. Growing awareness among the population regarding importance of early diagnosis and disease prevention have further accelerated growth of global fundus camera market. Technological advancements, such as the integration of wide-field imaging technology and portable cameras, are expected to drive innovation in the market. Government initiatives, regulatory policies, and collaborations between medical device companies and research institutions, are the factors that are driving growth in global fundus market.

Key Players Landscape and Outlook

In the fundus camera market, companies are progressively undergoing mergers and acquisitions, strategic partnerships, and distribution agreements, which are pivotal in driving the global fundus camera market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development endeavors. Distribution agreements enable companies to broaden their market presence at an international level. In November 2022, SDC Technologies, Inc., announced the acquisition of Coburn Technologies, Inc., an innovator in developing high quality, precision ophthalmic lens processing systems and instruments for the eye care industry. This strategic acquisition aims to broaden their product portfolio of highly efficient fundus cameras and gain insights into advanced lens processing technologies.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Fundus Camera Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. Mydriatic Fundus Cameras
    • 4.2.2. Non-Mydriatic Fundus Cameras
    • 4.2.3. Hybrid Fundus Cameras
    • 4.2.4. Others
  • 4.3. By Portability
    • 4.3.1. Hand-Held
    • 4.3.2. Table-Top
  • 4.4. By End-user
    • 4.4.1. Hospitals & Clinics
    • 4.4.2. Ophthalmology Clinics
    • 4.4.3. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. South America
    • 4.5.4. Asia-Pacific
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Fundus Camera Market Outlook, By Region, 2017-2031F

  • 5.1 North America*
    • 5.1.1 Market Size & Forecast
      • 5.1.1.1 Value
      • 5.1.1.2 Volume
    • 5.1.2 By Product
      • 5.1.2.1 Mydriatic Fundus Cameras
      • 5.1.2.2 Non-Mydriatic Fundus Cameras
      • 5.1.2.3 Hybrid Fundus Cameras
      • 5.1.2.4 Others
    • 5.1.3 By Portability
      • 5.1.3.1 Hand-Held
      • 5.1.3.2 Table-Top
    • 5.1.4 By End-user
      • 5.1.4.1 Hospitals & Clinics
      • 5.1.4.2 Ophthalmology Clinics
      • 5.1.4.3 Others
    • 5.1.5 United States*
      • 5.1.5.1 Market Size and Forecast
      • 5.1.5.1.1 Value
      • 5.1.5.1.2 Volume
      • 5.1.5.2 By Product
      • 5.1.5.2.1 Mydriatic Fundus Cameras
      • 5.1.5.2.2 Non-Mydriatic Fundus Cameras
      • 5.1.5.2.3 Hybrid Fundus Cameras
      • 5.1.5.2.4 Others
      • 5.1.5.3 By Portability
      • 5.1.5.3.1 Hand-Held
      • 5.1.5.3.2 Table-Top
      • 5.1.5.4 By End-user
      • 5.1.5.4.1 Hospitals & Clinics
      • 5.1.5.4.2 Ophthalmology Clinics
      • 5.1.5.4.3 Others
    • 5.1.6 Canada
    • 5.1.7 Mexico

All segments will be provided for all regions and countries covered

  • 5.2 Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 5.3 South America
    • 5.3.1 Brazil
    • 5.3.2 Argentina
  • 5.4 Asia-Pacific
    • 5.4.1 India
    • 5.4.2 China
    • 5.4.3 Japan
    • 5.4.4 Australia
    • 5.4.5 Vietnam
    • 5.4.6 South Korea
    • 5.4.7 Indonesia
    • 5.4.8 Philippines
  • 5.5 Middle East & Africa
    • 5.5.1 Saudi Arabia
    • 5.5.2 UAE
    • 5.5.3 South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Portability
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Topcon Corporation
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Kowa Company, Ltd.
  • 13.3. Canon Inc.
  • 13.4. Forus Health Pvt Ltd
  • 13.5. Nidek Co., Ltd.
  • 13.6. Remidio Innovative Solutions Pvt. Ltd.
  • 13.7. Epipole Ltd
  • 13.8. Coburn Technologies, Inc.
  • 13.9. Carl Zeiss AG
  • 13.10. Tamron Co., Ltd.
  • 13.11. Revenio Group Corporation
  • 13.12. Optomed Plc.
  • 13.13. Eyenuk Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦